
Wall Street Journal - October 4, 2002
Gautam Naik, Staff Reporter of The Wall Street Journal
The Netherlands' General Health Inspection Service said it was investigating a tiny Dutch company it identified as Asklepios for allegedly importing the shipments of two drugs made by GlaxoSmithKline PLC to the Netherlands and Germany. Asklepios "has refused cooperation," said Raymond Salet, spokesman for the General Health Inspection Service, an arm of the Dutch government. "We've handed the investigation over to the police."
Asklepios couldn't be reached for comment.
The shipments of Combivir and Epivir were meant for patients in the Congo, Senegal, the Ivory Coast and other West African countries, according to Mr. Salet. Instead, of the 36,000 boxes of drugs intended for Africa, about 30,000 boxes ended up on German pharmacy shelves, while the rest went to the Netherlands.
This is the first known case of AIDS drugs being diverted from Africa since Glaxo and others agreed two years ago to supply AIDS medication to poor countries under a preferential pricing arrangement. In the Netherlands, a package of 60 Combivir tablets -- one month's supply -- sells for about Ç400. By comparison, Glaxo makes Combivir available to certain African countries at discounts of as much as 90%.
Write to Gautam Naik at gautam.naik@wsj.com
021004
WJ021001
Copyright © 2002 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .